TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
YDES

YD Bio Ltd

Healthcare · Biotechnology

7.60$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement YDES
Line item 2020 2021 2022 2023 2024 2025
– – – 100.0% 100.0% 100.0%
– – – 56.2% 69.6% 107.1%
– – – 43.8% 30.4% -7.1%
– – – 0.0% 96.3% 268.4%
– – – 43.7% 220.3% 639.6%
– – – 46.6% 316.9% 876.2%
– – – -2.8% -286.5% -883.3%
– – – 0.6% 0.2% 0.0%
– – – 5.0% -271.7% -1,392.9%
– – – 1.2% 4.9% -0.3%
– – – 3.9% -276.6% -1,392.6%
– – – 6.4% -251.0% -1,357.8%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?